Fluorouracil
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00544 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | botryoid-type embryonal rhabdomyosarcoma of the vagina | KG + DL |
| 2 | rhabdomyosarcoma (disease) | KG + DL |
| 3 | parameningeal embryonal rhabdomyosarcoma | KG + DL |
| 4 | embryonal extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 5 | prostate embryonal rhabdomyosarcoma | KG + DL |
| 6 | extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 7 | liver sarcoma | KG + DL |
| 8 | sickle cell-hemoglobin c disease syndrome | KG + DL |
| 9 | sickle cell-hemoglobin d disease syndrome | KG + DL |
| 10 | hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | KG + DL |
| 11 | sickle cell-beta-thalassemia disease syndrome | KG + DL |
| 12 | sickle cell-hemoglobin E disease syndrome | KG + DL |
| 13 | female breast carcinoma | KG + DL |
| 14 | skeletal muscle neoplasm | KG + DL |
| 15 | carcinoma in situ of gastric body | KG + DL |
| 16 | carcinoma in situ of gastric cardia | KG + DL |
| 17 | Epstein-Barr virus-associated carcinoma | KG + DL |
| 18 | malignant gastric granular cell tumor | KG + DL |
| 19 | cardia cancer | KG + DL |
| 20 | malignant gastric germ cell tumor | KG + DL |
| 21 | gastric lymphoma | KG + DL |
| 22 | pylorus cancer | KG + DL |
| 23 | gastric cardia adenocarcinoma | KG + DL |
| 24 | retrograde amnesia | KG + DL |
| 25 | severe early-onset pulmonary alveolar proteinosis due to MARS deficiency | KG + DL |
| 26 | gastric adenocarcinoma and proximal polyposis of the stomach | KG + DL |
| 27 | benign neoplasm of stomach | KG + DL |
| 28 | well-differentiated fetal adenocarcinoma of the lung | KG + DL |
| 29 | microinvasive gastric cancer | KG + DL |
| 30 | gastric tubular adenocarcinoma | KG + DL |
| 31 | signet ring cell gastric adenocarcinoma | KG + DL |
| 32 | primary pulmonary lymphoma | KG + DL |
| 33 | acrocephalopolydactyly | KG + DL |
| 34 | cecum villous adenoma | KG + DL |
| 35 | pulmonary blastoma | KG + DL |
| 36 | cecum neuroendocrine tumor G1 | KG + DL |
| 37 | short stature-optic atrophy-Pelger-HuC+t anomaly syndrome | KG + DL |
| 38 | cecal disease | KG + DL |
| 39 | benign neoplasm of cecum | KG + DL |
| 40 | lipoma of colon | KG + DL |
| 41 | colonic lymphangioma | KG + DL |
| 42 | rectosigmoid junction neoplasm | KG + DL |
| 43 | colon leiomyoma | KG + DL |
| 44 | small cell lung carcinoma | KG + DL |
| 45 | Dengue hemorrhagic fever | KG + DL |
| 46 | gastric neuroendocrine neoplasm | KG + DL |
| 47 | cavernous hemangioma of colon | KG + DL |
| 48 | solid pseudopapillary carcinoma of pancreas | KG + DL |
| 49 | osteoclastic giant cell tumor of pancreas | KG + DL |
| 50 | pyloric antrum cancer | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.